The
novel PFOS alternatives, 6:2 chlorinated polyfluorinated ether
sulfonate (F-53B) and sodium p-perfluorous nonenoxybenzenesulfonate
(OBS), are emerging in the Chinese market, but little is known about
their ecological risks. In this study, zebrafish embryos were exposed
to PFOS, F-53B, and OBS to evaluate their bioconcentration and acute
metabolic consequences. Per- and polyfluoroalkyl substances (PFASs)
accumulated in larvae in the order of F-53B > PFOS > OBS, with
the
bioconcentration factors ranging from 20 to 357. Exposure to F-53B
and PFOS, but not OBS, increased energy expenditure, and reduced feed
intake in a concentration-dependent manner and the expression of genes
involved in metabolic pathways at the transcriptional and translational
levels. Molecular docking revealed that the binding affinities of
PFASs to glucokinase were decreased in the following order: F-53B
> PFOS > OBS. Finally, the results of Point of Departure (PoD)
indicate
that metabolic end points at the molecular and organismal level are
most sensitive to F-53B followed by PFOS and OBS. Collectively, F-53B
has the highest bioconcentration potential and the strongest metabolism-disrupting
effects, followed by PFOS and OBS. Our findings have important implications
for the assessment of early developmental metabolic effects of PFOS
alternatives F-53B and OBS in wildlife and humans.